TrialRMD open2026

Exploring possibilities towards PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA): tailored modifications to standard treat-to-target management-a multicentre, randomised, open-label trial.

Agnes E M Looijen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.